Related Experiment Video
Updated: Nov 21, 2025
16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.7K
First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping
Arianne Clare Agdamag1, Andrew Shaffer2, Ranjit John2
1Cardiovascular Division, Department of Internal Medicine, University of Minnesota, Minneapolis, Minnesota.
The Annals of Thoracic Surgery
|January 14, 2021
Summary
The Revivent TC System aids left ventricular reshaping but may not prevent end-stage heart failure. This case report details complex left ventricular assist device surgery after Revivent implantation, offering guidance for advanced heart failure teams.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Medical Devices
Background:
- The Revivent TC System offers a less invasive method for left ventricular reshaping and scar exclusion in ischemic cardiomyopathy.
- While designed to improve quality of life and promote reverse remodeling, progression to end-stage heart failure remains possible.
Observation:
- This report details a complex left ventricular assist device (LVAD) implantation performed 16 months after a patient received the Revivent System.
- The case highlights the intricate planning and surgical techniques required for such combined interventions.
Findings:
- Successful LVAD implantation was achieved in a patient with a history of Revivent System use.
- The case underscores the feasibility of advanced therapies in patients previously treated with ventricular remodeling devices.
Implications:
- This case report provides valuable insights for advanced heart failure teams managing patients with prior Revivent System implantation who require LVAD support.
- It can aid in optimizing surgical planning and execution for complex, multi-stage cardiac interventions.
- The findings contribute to the understanding of managing ischemic cardiomyopathy progression in patients undergoing device-based ventricular repair.
